Natural Alternativ (NAII) Stock Price, Quote & News

Company Profile

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategi...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 760 744 7700

Website: www.nai-online.com

Address:

1535 Faraday Avenue, Carlsbad, United States

BillionerOfKing Feb. 19 at 11:43 AM

$NAII Current Stock Price: $2.60

0 · Reply

ZacksResearch Feb. 18 at 5:03 PM

$NAII sales up… but losses widening — and guidance getting cut. Not the combo bulls want to see. Q2 sales increased year over year, but losses widened, and the company trimmed its outlook for fiscal 2026 due to softer customer forecasts and launch delays. Growth is there, but profitability and visibility are clearly under pressure. ⚠️ Find out what this means for the investment case 👉 https://www.zacks.com/stock/news/2871435/natural-alternatives-q2-loss-widens-yy-sales-increase?cid=sm-stocktwits-2-2871435-teaser-34043&ADID=SYND_STOCKTWITS_TWEET_2_2871435_TEASER_34043

0 · Reply

ZacksResearch Feb. 18 at 4:03 PM

$NAII takes a 25.3% hit since Q2 results — what's behind the plunge? 😮 📉 Q2 net loss widens to $2.6M, while sales rise a modest 2% ⚡️ Challenges in forecasting demand & underutilized capacity weigh heavily 👐 Cash reserves drop to $3.8M, reducing liquidity cushion Full breakdown here 👇 https://www.zacks.com/stock/news/2871435/natural-alternatives-q2-loss-widens-yy-sales-increase?cid=sm-stocktwits-2-2871435-body-34040&ADID=SYND_STOCKTWITS_TWEET_2_2871435_BODY_34040

0 · Reply

JeremyKamal269 Feb. 18 at 1:43 PM

$NAII Defense electronics supplier with contract exposure.

0 · Reply

OfficialStocktwitsUser Feb. 17 at 9:47 PM

$NAII RSI: 21.59, MACD: -0.2242 Vol: 0.53, MA20: 3.76, MA50: 3.70 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

UgoGreg Feb. 17 at 4:42 PM

$NAII https://youtu.be/ygBN8MilTyc

0 · Reply

UgoGreg Feb. 17 at 4:32 PM

$NAII https://youtu.be/rMFBKsc5z0g

0 · Reply

PortfolioEminence Feb. 17 at 1:21 PM

$NAII Obscure micro-cap; likely a shell.

0 · Reply

GammaGainz Feb. 9 at 3:34 PM

$NAII Natural alternatives or biotech; requires clinical proof for products.

0 · Reply

OfficialStocktwitsUser Feb. 5 at 11:35 AM

$NAII RSI: 19.54, MACD: 0.0352 Vol: 0.34, MA20: 4.28, MA50: 3.74 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

Nov 12, 2025, 4:44 PM EST - 3 months ago

Natural Alternatives International, Inc. Announces 2026 Q1 Results

Sep 23, 2025, 4:30 PM EDT - 5 months ago

Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

Jul 21, 2025, 4:30 PM EDT - 7 months ago

Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company

Jun 23, 2025, 4:15 PM EDT - 8 months ago

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

May 14, 2025, 5:24 PM EDT - 10 months ago

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

Mar 5, 2025, 3:20 PM EST - 1 year ago

Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination

Feb 14, 2025, 4:30 PM EST - 1 year ago

Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results

Nov 13, 2024, 4:30 PM EST - 1 year ago

Natural Alternatives International, Inc. Announces 2025 Q1 Results

Oct 24, 2024, 5:50 PM EDT - 1 year ago

CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients

Sep 27, 2024, 7:20 PM EDT - 1 year ago

Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results

Aug 26, 2024, 8:00 AM EDT - 1 year ago

CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism

May 14, 2024, 4:30 PM EDT - 1 year ago

Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs

Feb 15, 2024, 11:00 AM EST - 2 years ago

CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine

Feb 13, 2024, 4:30 PM EST - 2 years ago

Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results

Nov 9, 2023, 5:01 PM EST - 2 years ago

Natural Alternatives International, Inc. Announces 2024 Q1 Results

Sep 21, 2023, 4:15 PM EDT - 2 years ago

Natural Alternatives International, Inc. Announces 2023 Q4 and YTD Results

Aug 16, 2023, 4:15 PM EDT - 2 years ago

Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs

Jul 25, 2023, 9:00 AM EDT - 2 years ago

Natural Alternatives International Appoints New VP of Global Sales

May 31, 2023, 10:00 AM EDT - 2 years ago

SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023

May 24, 2023, 10:00 AM EDT - 2 years ago

Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California

May 17, 2023, 1:30 PM EDT - 3 years ago

Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting

May 15, 2023, 4:30 PM EDT - 3 years ago

Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results

Feb 23, 2023, 8:00 AM EST - 3 years ago

NEWLY PUBLISHED STUDY SHOWS SR CARNOSYN® BETA-ALANINE IMPROVES COGNITIVE FUNCTION IN OLDER ADULTS

Feb 8, 2023, 4:30 PM EST - 3 years ago

Natural Alternatives International, Inc. Announces 2023 Q2 and YTD Results

Jan 13, 2023, 11:38 AM EST - 3 years ago

Natural Alternatives: Low Moat And Trading At Cycle Peak Multiples

Dec 5, 2022, 4:15 PM EST - 3 years ago

Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase Plan

Nov 9, 2022, 4:59 PM EST - 3 years ago

Natural Alternatives International, Inc. Announces 2023 Q1 Results

Sep 21, 2022, 4:30 PM EDT - 3 years ago

Natural Alternatives International, Inc. Announces 2022 Q4 and YTD Results

May 13, 2022, 9:15 AM EDT - 4 years ago

Natural Alternatives International, Inc. Announces 2022 Q3 and YTD Results

Apr 21, 2022, 5:00 PM EDT - 4 years ago

NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

Feb 9, 2022, 4:30 PM EST - 4 years ago

Natural Alternatives International, Inc. Announces 2022 Q2 and YTD Results

Jan 31, 2022, 11:00 AM EST - 4 years ago

NATURAL ALTERNATIVES INTERNATIONAL ADDS SHERRI BALZER AS BUSINESS DEVELOPMENT MANAGER FOR CARNOSYN® BRANDS

Jan 18, 2022, 9:15 AM EST - 4 years ago

Natural Alternatives International, Inc. Announces a $3 Million Increase in its Stock Repurchase Plan

Nov 9, 2021, 4:30 PM EST - 4 years ago

Natural Alternatives International, Inc. Announces 2022 Q1 Results

Oct 27, 2021, 11:35 AM EDT - 4 years ago

Natural Alternatives International And CarnoSyn® Brands To Attend SupplySide West Show

Sep 21, 2021, 6:23 AM EDT - 4 years ago

Natural Alternatives Posts 26% Revenue Growth In Q4

Sep 20, 2021, 4:57 PM EDT - 4 years ago

Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results

Aug 24, 2021, 9:15 AM EDT - 4 years ago

Natural Alternatives International, Inc. Announces Acquisition of Manufacturing and Warehouse Facility

May 27, 2021, 4:00 PM EDT - 5 years ago

Natural Alternatives International, Inc. Announces New and Expanded Credit Facility with Wells Fargo Bank

May 13, 2021, 4:30 PM EDT - 5 years ago

Natural Alternatives International, Inc. Announces 2021 Q3 and YTD Results

Feb 23, 2021, 4:15 PM EST - 5 years ago

Natural Alternatives International, Inc. Announces Release of Investor Presentation

Feb 9, 2021, 4:30 PM EST - 5 years ago

Natural Alternatives International, Inc. Announces 2021 Q2 and YTD Results

Feb 3, 2021, 9:30 AM EST - 5 years ago

Natural Alternatives International, Inc. Announces that it has repaid all amounts outstanding under its credit line

Nov 10, 2020, 4:30 PM EST - 5 years ago

Natural Alternatives International, Inc. Announces 2021 Q1 Results

Sep 21, 2020, 4:38 PM EDT - 5 years ago

Natural Alternatives International, Inc. Announces Fiscal Year 2020 and Q4 Results

Sep 2, 2020, 12:00 PM EDT - 5 years ago

Dr. Nancy Steely Appointed Vice President, Research and Development At Natural Alternatives International, Inc.

May 14, 2020, 4:30 PM EDT - 6 years ago

Natural Alternatives International, Inc. Announces 2020 Q3 and YTD Results

BillionerOfKing Feb. 19 at 11:43 AM

$NAII Current Stock Price: $2.60

0 · Reply

ZacksResearch Feb. 18 at 5:03 PM

0 · Reply

ZacksResearch Feb. 18 at 4:03 PM

0 · Reply

JeremyKamal269 Feb. 18 at 1:43 PM

$NAII Defense electronics supplier with contract exposure.

0 · Reply

OfficialStocktwitsUser Feb. 17 at 9:47 PM

0 · Reply

UgoGreg Feb. 17 at 4:42 PM

$NAII https://youtu.be/ygBN8MilTyc

0 · Reply

UgoGreg Feb. 17 at 4:32 PM

$NAII https://youtu.be/rMFBKsc5z0g

0 · Reply

PortfolioEminence Feb. 17 at 1:21 PM

$NAII Obscure micro-cap; likely a shell.

0 · Reply

GammaGainz Feb. 9 at 3:34 PM

$NAII Natural alternatives or biotech; requires clinical proof for products.

0 · Reply

OfficialStocktwitsUser Feb. 5 at 11:35 AM

0 · Reply

Nchakoo Jan. 26 at 3:17 PM

$NAII a Big ‘W’ will form shortly - stay invested - very bullish >$10

0 · Reply

ZacksResearch Jan. 15 at 4:38 PM

Niche healthcare is where the real edge is forming 👀 $CPIX, $NAII and $ICCC are carving out durable lanes while others fight crowded markets. These firms are leaning into specialization, regulatory compliance, and targeted growth to compete — a strategy that’s proving effective in niche healthcare segments where focus matters most. See how niche focus and regulation are shaping the winners 👉 https://www.zacks.com/stock/news/2818242/niche-focus-regulation-shape-the-future-of-healthcare-firms?cid=sm-stocktwits-2-2818242-teaser-29118&ADID=SYND_STOCKTWITS_TWEET_2_2818242_TEASER_29118

0 · Reply

Nchakoo Jan. 14 at 1:31 PM

$NAII very Bullish > $10 price target

0 · Reply

ChazzyTrades Jan. 12 at 6:34 PM

$NAII Bought here

0 · Reply

ChazzyTrades Jan. 12 at 4:59 PM

$NAII hmm might buy here

0 · Reply

RunnerSignals Jan. 1 at 4:03 PM

$INGR $IFF $NAII $LSF $NATR Is healthy food the next rotation? charts are waking up in clean labels small caps… feels early. full analysis worth a look https://stocksrunner.com/news/2026-01-01-will-the-wellness-trend-lift-healthy-food-stocks-in-2026

0 · Reply

SuperGreenToday Jan. 1 at 8:48 AM

$NAII

0 · Reply

tradingtrends24 Nov. 24 at 10:11 PM

$INBP is the cheapest supplements company out there. Supplier to $HLF and Life Extension. Only $9 million market cap with $5 million in cash and no debt. Trading for 2x ebitda, with tangible book value over 100% higher. Billionaire founders of Celsius $CELH own 40%+ of the stock. $NAII

0 · Reply

DismAssetBkd Nov. 24 at 9:11 PM

$NAII

0 · Reply

kshonstocks Nov. 24 at 6:20 PM

$NAII 200 dma b/o

0 · Reply

DismAssetBkd Nov. 13 at 4:38 PM

$NAII

0 · Reply

UnicornPicks Nov. 13 at 4:35 PM

$CURI $NAII $LVLU $BWEN

0 · Reply

Market Cap	15.78M
Revenue (ttm)	129.86M
Net Income (ttm)	-13.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.46%
Debt to Equity Ratio	0.04

Volume	39,257
Avg Vol	18,910
Day's Range	N/A - N/A
Shares Out	6.18M
Stochastic %K	18%
Beta	0.35
Analysts	Strong Buy
Price Target	N/A